Omeros (OMER) Current Leases (2018 - 2026)
Omeros (OMER) posted Current Leases of $6.4 million for Q1 2026, up 1.81% sequentially from $6.3 million in Q4 2025, and up 5.91% YoY from $6.1 million in Q1 2025.
Omeros (OMER) Current Leases (2018 - 2026) Analysis & Trends
Omeros has reported Current Leases for 9 years, with the latest figure at $6.4 million in Q1 2026.
- Quarterly Current Leases rose 5.91% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 5.91% YoY) and the FY2025 annual result came in at $6.3 million, up 5.51% from the prior year.
- Current Leases climbed to $6.4 million in Q1 2026 per OMER's latest filing, from $6.3 million in the prior quarter.
- Over five years, Current Leases peaked at $6.4 million in Q1 2026 and troughed at $3.9 million in Q1 2022.
- A 5-year average of $5.3 million and a median of $5.3 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2024: Current Leases retreated 17.98% in 2022, then climbed 20.67% in 2024.
- Over 5 years, Current Leases stood at $4.3 million in 2022, then grew by 19.72% to $5.2 million in 2023, then rose by 15.72% to $6.0 million in 2024, then increased by 5.51% to $6.3 million in 2025, then rose by 1.81% to $6.4 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $6.4 million, $6.3 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn | 6.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.58 Mn |
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 6.30 Mn |
| Sep 30, 2025 | 6.18 Mn |
| Jun 30, 2025 | 6.15 Mn |
| Mar 31, 2025 | 6.06 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 5.57 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 4.69 Mn |
| Mar 31, 2023 | 4.43 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Dec 31, 2021 | 5.26 Mn |
| Sep 30, 2021 | 5.09 Mn |